Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

503 public trials 139 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Active, Not Recruiting

A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)

NCT04529772

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Irvine, California, United States
  • Research Site Aurora, Colorado, United States
View all 243 locations
View Trial Details
Active, Not Recruiting

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

NCT04161248

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • University Health Network Toronto, Ontario, Canada
  • The Jewish General Hospital Montreal, Quebec, Canada
View Trial Details
Active, Not Recruiting

A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

NCT04594642

Conditions
B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +13 more
Locations
  • Research Site Tampa, Florida, United States
  • Research Site Louisville, Kentucky, United States
  • Research Site New Brunswick, New Jersey, United States
  • Research Site Charlotte, North Carolina, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mayo Clinic Hospital ( Site 0140) Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology ( Site 0017) Los Angeles, California, United States
  • Colorado Blood Cancer Institute ( Site 0225) Denver, Colorado, United States
  • University of Michigan ( Site 0018) Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

NCT05784441

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Iowa Hospital Iowa City, Iowa, United States
  • University of Kentucky Lexington, Kentucky, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Rutgers University New Brunswick, New Jersey, United States
View all 15 locations
View Trial Details

Related conditions